Bausch Health Companies (BHC) Short term Debt (2009 - 2026)
Bausch Health Companies (BHC) posted Short term Debt of $866.0 million for Q2 2026, down 2.59% sequentially from $889.0 million in Q1 2026, and down 1.48% YoY from $879.0 million in Q2 2025.
Bausch Health Companies (BHC) Short term Debt (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Short term Debt for 17 years, with the latest figure at $866.0 million in Q2 2026.
- Quarterly Short term Debt fell 1.48% year-over-year to $866.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $866.0 million (down 1.48% YoY) and the FY2025 annual result came in at $225.0 million, down 91.59% from the prior year.
- Short term Debt retreated to $866.0 million in Q2 2026 per BHC's latest filing, from $889.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $2.7 billion in Q4 2024 and troughed at $150.0 million in Q2 2022.
- A 5-year average of $629.8 million and a median of $452.0 million in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2024 and 2025: Short term Debt surged 494.22% in 2024, then tumbled 91.59% in 2025.
- Over 5 years, Short term Debt stood at $432.0 million in 2022, then climbed by 4.17% to $450.0 million in 2023, then soared by 494.22% to $2.7 billion in 2024, then sank by 91.59% to $225.0 million in 2025, then soared by 284.89% to $866.0 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $866.0 million, $889.0 million, and $225.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.38 Bn | 30.70 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.49 Bn | 655.79 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 866.00 Mn |
| Mar 31, 2026 | 889.00 Mn |
| Dec 31, 2025 | 225.00 Mn |
| Sep 30, 2025 | 579.00 Mn |
| Jun 30, 2025 | 879.00 Mn |
| Mar 31, 2025 | 282.00 Mn |
| Dec 31, 2024 | 2.67 Bn |
| Sep 30, 2024 | 453.00 Mn |
| Jun 30, 2024 | 452.00 Mn |
| Mar 31, 2024 | 538.00 Mn |
| Dec 31, 2023 | 450.00 Mn |
| Sep 30, 2023 | 536.00 Mn |
| Jun 30, 2023 | 444.00 Mn |
| Mar 31, 2023 | 446.00 Mn |
| Dec 31, 2022 | 432.00 Mn |
| Sep 30, 2022 | 411.00 Mn |
| Jun 30, 2022 | 150.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 4.00 Mn |
| Dec 31, 2019 | 1.23 Bn |